Objective assessment of gastric function after vagotomy.
D004381:Duodenal Ulcer / Q000503:physiopathology; D005260:Female; D005745:Gastric Acidity Determination; D005750:Gastric Juice / Q000378:metabolism*; D005755:Gastrins / Q000097:blood / Q000502:physiology; D005769:Gastrointestinal Motility; D005947:Glucose / Q000378:metabolism; D006632:Histamine; D049673:History, 20th Century; D006801:Humans; D007328:Insulin / Q000008:administration & dosage; D008297:Male; D008751:Methylene Blue; D009416:Nerve Regeneration; D010418:Pentagastrin; D010434:Pepsin A / Q000378:metabolism; D010437:Peptic Ulcer / Q000601:surgery; D011178:Postgastrectomy Syndromes / Q000503:physiopathology; D011300:Preoperative Care; D011706:Pyloric Antrum / Q000502:physiology; D011863:Radioimmunoassay; D012008:Recurrence; D012737:Sex Factors; D013270:Stomach / Q000187:drug effects / Q000294:innervation / Q000502:physiology*; D013562:Sympathectomy; D013997:Time Factors; D014628:Vagotomy / Q000266:history
D005755:Gastrins; D007328:Insulin; D006632:Histamine; D010434:Pepsin A; D010418:Pentagastrin; D005947:Glucose; D008751:Methylene Blue